Third Rock Ventures IV, L.P., 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 175,000 shares at $11.60 ($2.0M) on 2024-08-30, disclosed to the SEC on 2024-09-04.
Open-market sale of $2.0M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| TNGX | SELL | 2024-07-22 | $3.8M | — | Filing → |
| TNGX | SELL | 2024-02-21 | $1.9M | — | Filing → |